Management of gastrointestinal symptoms in advanced cancer patients: The rapid learning cancer clinic model

Current Opinion in Supportive and Palliative Care

Volumn 4, Issue 1, 2010, Pages 36-45

  Abernethy, Amy P ^a   Wheeler, Jane L ^a   Zafar, S Yousuf ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Digestive (MeSH); Palliative care (MeSH); Patient reported outcomes; Rapid learning healthcare; Signs and symptoms; Terminal care (MeSH)

Indexed keywords

GASTROINTESTINAL DISEASE; HOSPITALIZATION; HUMAN; INTERNET; MEDICAL RECORD; METHODOLOGY; NEOPLASM; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; REVIEW;

GASTROINTESTINAL DISEASES; HUMANS; INTERNET; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; SEVERITY OF ILLNESS INDEX;

EID: 77950359833     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32833575fd     Document Type: Review

References (54)

1. NCI. Nausea and vomiting; 2008. http://www.cancer.gov/cancertopics/pdq/ supportivecare/nausea/HealthProfessional/.
2. Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 2006; 14:348-353.
3. Naeim A, Dy SM, Lorenz KA, et al. Evidence-based recommendations for cancer nausea and vomiting. J Clin Oncol 2008; 26:3903-3910.
4. Teunissen SCCM, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34:94-104.
5. NCI. Gastrointestinal complications; 2008. http://www.cancer.gov/ cancertopics/pdq/supportivecare/gastrointestinalcomplications/ HealthProfessional/
6. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000; 89:1634-1646.
7. Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004; 22:2918-2926.
8. Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002; 24:71-90.
9. Mostafa SM, Bhandari S, Ritchie G, et al. Constipation and its implications in the critically ill patient. Br J Anaesth 2003; 91:815-819.
10. Smith S. Evidence-based management of constipation in the oncology patient. Eur J Oncol Nurs 2001; 5:18-25.
11. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 1998; 12:375-382.
12. Kyle G. Constipation and palliative care: where are we now? Int J Palliat Nurs 2007; 13:6-16.
13. Dunlop G. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far advanced cancer: student paper. Palliat Med 1989; 4:37-44.
14. Holmes S. Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 1989; 26:69-79.
15. Hurdon V, Viola R, Schroder C. How useful is docusate in patients at risk for constipation? A systematic review of the evidence in the chronically ill. J Pain Symptom Manage 2000; 19:130-136.
16. Wilke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 2004; 25:535-552.
17. Doward LC, McKenna SP. Defining patient-reported outcomes. Value Health 2004; 7 (Suppl 1):S4-S8.
18. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997; 33:1025-1030.
19. Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 1997; 6:151-158.
20. Cella D, Webster K. Linking outcomes management to quality-of-life measurement. Oncology 1997; 11 (11A):232-235.
21. Fransen GAJ, Janssen MJR, Muris JWM, et al. Measuring the severity of upper gastrointestinal complaints: does GP assessment correspond with patients' self-assessment? Fam Pract 2007; 24:252-258.
22. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 2006; 7:903-909.
23. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well being: a randomized controlled trial. J Clin Oncol 2004; 22:714-724.
24. Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 2007; 25:5121-5127.
25. Basch E, Iasonos A, Barz A, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007; 25:5374-5380.
26. Meyer F, Fortin A, Gelinas M, et al. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 2009; 27:2970-2976.
27. Browman GP, Berrang T, Smith S. Prognostic tools for cancer survival: a secondary role for quality-of-life measurement. J Clin Oncol 2009; 27:2902-2904.
28. McKernan M, McMillan DC, Anderson JR, et al. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008; 98:888-893.
29. Robinson DW Jr, Eisenberg DF, Cella D, et al. The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol 2008; 6:283-290.
30. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clinl Oncol 2008; 26:1355-1363.
31. Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009; 10:865-871.
32. Ruland CM. Handheld technology to improve patient care: evaluating a support system for preference-based care planning at the bedside. J Am Med Inform Assoc 2002; 9:192-201.
33. Wood A, Pisters K, Chi M, et al. Evaluation of antiemetic guidelines and outcomes in patients receiving highly emetogenic chemotherapy utilizing the palm pilot [abstract #2512]. Proc Am Soc Clin Oncol 2000; 19.
34. Kaasa S, Loge JH, Fayers P, et al. Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 2008; 26:3867-3873.
35. Trust SACotMO. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11:193-205.
36. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570-579.
37. United States Department of Health and Human Services. Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims, draft guidance; 2006.
38. United States Food and Drug Administration. FDA to release final guidance on patient-reported outcomes. FDA News Drug Daily Bull 2009; 6.
39. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paperand-pencil administration of patient-reported outcome measures: a metaanalytic review. Value Health 2008; 11:322-333.
40. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997; 15:974-986. (Pubitemid 27106280)
41. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemiarelated symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13:63-74.
42. Lorig K, Chastain RL, Ung E, et al. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989; 32:37-44.
43. Fortner B, Okon T, Schwartzberg L, et al. The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 2003; 26:1077-1092.
44. Abernethy AP, Herndon JE 2nd, Wheeler JL, et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J Pain Symptom Manage 2009; 37:1027-1038.
45. Abernethy AP, Herndon JE, Wheeler JL, et al. Improving healthcare efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res 2008; 43:1975-1991.
46. Abernethy AP, Zafar SY, Coeytaux R, et al. Electronic patient-reported data capture as the foundation of a learning healthcare system [abstract #6522]. J Clin Oncol 2009; 27(15S)
47. Institute of Medicine. The learning healthcare system: workshop summary (IOM Roundtable on Evidence-based Medicine). Washington, District of Columbia, USA: The National Academies Press; 2007.
48. Etheredge LM. A rapid-learning health system. Health Affairs 2007; 26:w107-w118.
49. Etheredge LM. Medicare's future: cancer care. Health Affairs 2009; 28:148-159.
50. Buetow KH, Niederhuber J. Infrastructure for a learning healthcare system: CaBIG. Health Affairs 2009; 28:923-924; author reply 924-925.
51. Slutsky JR. Moving closer to a rapid-learning healthcare system [comment]. Health Affairs 2007; 26:w122-w124.
52. Garcia SF, Cella D, Clauser SB, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 2007; 25:5106-5112.
53. Dupont A, Wheeler J, Herndon JE 2nd, et al. Use of tablet personal computers for sensitive patient-reported information. J Support Oncol 2009; 7:91-97.
54. Abernethy AP, Wheeler JL, Zafar SY. Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach. Curr Opin Support Palliat Care 2009; 3:41-49.